Loading...
Symbols:
BIOV Forum Topics
- All Comments on BIOV
- General Discussion on BIOV
- Biotech Day In Review: Roche Buys BioVeris For $600 Million [view article]
loading ...Recent BIOV Articles
- Biotech Week In Review: Positive Territory For 2007
- BioVeris Acquisition by Roche Highlights Importance of Diagnostics
- Biotech Day In Review: Roche Buys BioVeris For $600 Million
- Biotech Week In Review: Biotech Treks Higher
- Biotech Stocks Day-In-Review: Amgen Drags Biotech Lower
- Biotech Indices Mixed as AMEX Gains, Nasdaq Slips
- Full List of Articles »
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
Editors
General Discussion on BIOV
Is this a buy or a sell? ReplyBiotech Day In Review: Roche Buys BioVeris For $600 Million [view article]
Can any experienced successful biotech investor either concur or disagree with the following please.symbol:NSTK price:$11.12
Based on fundamentals,poor earnings,ratings,delay... payments by PG for another 9-12 months, and a slated 2009 potential approval, for its obesity drug,and knowing in advance the March and December 2007 earnings reports
showing a loss, isn't it wise to at this time, not to be invested in this stock, based upon all the writing on the wall?
JT Reply